GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification
/PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, is partnering with Allozymes, a...
Stay updated with breaking news from Genscript Asia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, is partnering with Allozymes, a...
SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP. The Thai FDA has approved VAILL COVITRAP as a Class 4 medical device, making Thailand the first country to approve the manufact...